Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-027174
Filing Date
2020-05-05
Accepted
2020-05-05 16:53:48
Documents
2
Period of Report
2020-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1583
2 EX-24 DOCUMENT attachment1.htm EX-24 2754
  Complete submission text file 0001209191-20-027174.txt   6014
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA BIOSCIENCES, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054
Business Address
Manning Donald C. (Reporting) CIK: 0001775268 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35060 | Film No.: 20849723